Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Germline Variants in Patients From the Iranian Hereditary Colorectal Cancer Registry Publisher



Goshayeshi L1, 2 ; Hoorang S3 ; Hoseini B4 ; Abbaszadegan MR5 ; Afrazeh M6 ; Alimardani M5 ; Maghool F7 ; Shademan M8 ; Zahedi M2 ; Zeinalian M9 ; Alborzi F10 ; Keramati MR11 ; Torshizian A12 ; Vosoghinia H13 Show All Authors
Authors
  1. Goshayeshi L1, 2
  2. Hoorang S3
  3. Hoseini B4
  4. Abbaszadegan MR5
  5. Afrazeh M6
  6. Alimardani M5
  7. Maghool F7
  8. Shademan M8
  9. Zahedi M2
  10. Zeinalian M9
  11. Alborzi F10
  12. Keramati MR11
  13. Torshizian A12
  14. Vosoghinia H13
  15. Rajabzadeh F14
  16. Bary A15
  17. Bahar M16
  18. Javadmanesh A17, 18
  19. Sorourikhorashad J19
  20. Emami MH7
  21. Daryani NE10
  22. Vasen HFA20
  23. Goshayeshi L1, 2
  24. Dehghani H2, 21
Show Affiliations
Authors Affiliations
  1. 1. Surgical Oncology Research Center, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  2. 2. Stem Cell Biology and Regenerative Medicine Research Group, Research Institute of Biotechnology, Ferdowsi University of Mashhad, Azadi Square, Mashhad, 91779-48974, Iran
  3. 3. Department of Gastroenterology and Hepatology, Abu Ali Sina Hospital, Shiraz, Iran
  4. 4. Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
  5. 5. Department of Medical Genetics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  6. 6. Department of Gastroenterology and Hepatology, Faculty of Medicine, Neyshabur University of Medical Sciences, Mashhad, Iran
  7. 7. Poursina Hakim Digestive Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  8. 8. Department of Human Genetics, Leiden University Medical Center, Leiden, Netherlands
  9. 9. Department of Genetics & Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  10. 10. Department of Gastroenterology and Hepatology, Tehran University of Medical Sciences, Tehran, Iran
  11. 11. Division of Colorectal Surgery, Department of Surgery, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  12. 12. Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  13. 13. Department of Gastroenterology and Hepatology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  14. 14. Department of Radiology, Mashhad Branch, Islamic Azad University, Mashhad, Iran
  15. 15. Hematology-Oncology Department, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  16. 16. Familial & Hereditary Cancers Institute, Tehran, Iran
  17. 17. Department of Animal Science, Faculty of Agriculture, Ferdowsi University of Mashhad, Mashhad, Iran
  18. 18. Industrial Biotechnology Research Group, Research Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran
  19. 19. Centre for Molecular Pathology, Royal Marsden Hospital, Institue of Cancer Research, London, United Kingdom
  20. 20. Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, Netherlands
  21. 21. Department of Basic Sciences, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran

Source: Cancer Cell International Published:2025


Abstract

Background and aim: Hereditary cancer syndromes account for 6–10% of all colorectal cancer (CRC) cases and 20% of early-onset CRC. Identifying novel pathogenic germline variants can impact genetic testing, counseling, and surveillance. This study aimed to determine the prevalence of germline variants associated with hereditary CRC in the Iranian population. Methods: Whole exome sequencing (WES) was conducted on DNA from 101 patients in the Iranian Hereditary Colorectal Cancer Registry (IHCCR). The cohort included 63 high-risk Lynch Syndrome (LS) patients and 38 colorectal polyposis patients. Germline variants and phenotype spectrum were assessed. Relatives of individuals with the mutations received counseling and cascade testing. Gene ontology and protein-protein interaction (PPI) analyses were conducted to elucidate gene roles on protein function. Results: Pathogenic/likely pathogenic (P/LP) variants were identified in Lynch-related genes in 36.51% of patients. P/LP variants in non-Lynch genes (ATM, FH (mono-allelic), MSH3, PMS1, and TP53) were identified in 26.98% of patients. Among polyposis patients, 50% had P/LP variants in the APC gene, and 15.79% had P/LP variants in the MUTYH gene. Additionally, 7.89% carried P/LP variants in non-FAP/MAP genes (BLM, BRCA2, and PTEN). MLH1 variants were most common in exons 10 and 18, MSH2 in exon 12, and APC gene in exon 16. Cascade testing identified 50% of the tested relatives (40/80). Topology analysis of the protein-protein interaction networks in high-risk LS cases highlighted stronger connections among nodes for genes such as TP53, ATM, POLD1, CDH1, MUTYH, WRN, NOTCH1, SMAD4, ERCC4, ERCC1, and MSH3. These genes were associated with high penetrance in CRC. The protein-protein interaction analyses of polyposis patients indicated that genes like POLE, MSH6, MSH2, BRCA2, BRCA1, MLH1, TOPBP1, BLM, RAD50, MUTYH, MSH3, MLH3, PTEN, BRIP1, and POLK had a higher degree value and were also associated with high penetrance. Gene ontology and protein-protein interaction (PPI) analysis showed that some of the top-scoring non-Lynch genes were TP53, ATM, POLD1, CDH1, MUTYH, WRN, NOTCH1, SMAD4, ERCC4, ERCC1, and MSH3. Conclusions: The study identified crucial germline variants for hereditary polyposis and non-polyposis CRC pathogenesis in the Iranian population. A selective strategy and cascade genetic testing are recommended for the diagnosis of hereditary colorectal cancer syndromes. © The Author(s) 2025.
Other Related Docs